Blocking polyphosphates could help treat chronic infections

Most disease-causing bacteria are known for their speed: In mere minutes, they can double their population, quickly making a person sick.

CBD can be used safely in women with advanced breast cancer and clinical anxiety

This Phase II trial explores CBD for anxiety in breast cancer patients, indicating safety and potential anxiolytic effects despite no primary outcome success.

December 18, 2024

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update – Biotech Investments

Issuer: CureVac / Key word(s): Quarter Results 12.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Financial

November 13, 2024

Orasis snags $78M to launch presbyopia eye drops more than a year after FDA approval

Last October was an FDA approval. This October is a $68 million fundraising round. Next year, maybe a drug launch. Orasis Pharmaceuticals … Sign up

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.